You are here

Primo Nutraceuticals Inc.

Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
PRMO
CSE Index: 
Currency: 

About Primo Nutraceuticals, Inc.

Primo Nutraceuticals Inc. Cannabis Production, Processing, Retail & Branding - Primo Nutraceuticals Inc. ("Primo" or the "Company") provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo provides fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. In addition to the Company's flagship hemp project in Oregon State and the Greenhouse campus in Washington State, Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo's management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets - offering "Thrive," "Primo," and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

You are here

Primo Nutraceuticals Inc. (PRMO)

SEDAR Information

Company Info

Address
Suite 440, 890 West Pender St.
Vancouver, BC V6C 1J9
Canada
Phone
1-877-517-7816
Email
info@primoceuticals.com
Website
http://primonutraceuticals.com/
Listing date
Friday, August 31, 2018
Transfer Agent
Integral Transfer Agency Shareholder Services
Email
info@primoceuticals.com

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
137,062,014
Reserved for Issuance: 
1,961,549

Bulletins

05/12/2019

2019-1207 - Suspension – Primo Nutraceuticals Inc. (PRMO)

Le 05 decembre/December 2019

Effective immediately Primo Nutraceuticals Inc., is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.  Cease trade orders have been issued by the Ontario Securities Commission and British Columbia Securities Commission.

Advertisement

Publicité

Latest CSE News

Upcoming Events

12_08_ELEV8CON_2019_Las_Vegas_Website

ELEV8CON 2019 Las Vegas

Sunday, December 8, 2019 (All day) to Wednesday, December 11, 2019 (All day)
12_09_Investor_Intelligence_Conference_2019_Website

Investor Intelligence Conference 2019

Monday, December 9, 2019 (All day) to Tuesday, December 10, 2019 (All day)
12_10_14th_MA_Forum_Montreal_Website

14th M&A Forum Montréal

Tuesday, December 10, 2019 -
7:00am to 7:00pm